ROLE OF RVR AND VIRAL LOAD ON SVR IN TREATMENT OF GT3 HEPATITIS C PATIENTS WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) IN REAL LIFE

被引：0

作者：

Zehnter, E. ^{[1
]}

Hueppe, D. ^{[2
]}

Kaiser, S. ^{[3
]}

Schober, A. ^{[4
]}

Schuchmann, M. ^{[5
]}

Boeker, K. ^{[6
]}

Moog, G. ^{[7
]}

Schiffelholz, W. ^{[8
]}

Pape, S. ^{[9
]}

Heyne, R. ^{[10
,11
]}

Ackermann, F. ^{[12
]}

Schmidt, W.

John, C.

Lohmeyer, J. ^{[13
]}

Hey, K. -H. ^{[9
]}

Alshuth, U. ^{[14
]}

Mauss, S. ^{[15
]}

机构：

[1] Ctr Gastroenterol, Dortmund, Germany

[2] Ctr Gastroenterol, Herne, Germany

[3] Hosp Eberhard Karls Univ, Tubingen, Germany

[4] Ctr Gastroenterol, Gottingen, Germany

[5] Hosp Johannes Gutenberg Univ, Mainz, Germany

[6] Ctr Gastroenterol, Hannover, Germany

[7] Ctr Gastroenterol, Kassel, Germany

[8] Ctr Gastroenterol, Augsburg, Germany

[9] Ctr Gastroenterol, Paderborn, Germany

[10] Ctr Gastroenterol, Berlin, Germany

[11] Ctr Liver, Berlin, Germany

[12] Meddata GmbH, Schkeuditz, Germany

[13] Univ Giessen, Giessen, Germany

[14] Roche Pharma AG, Hepatitis HIV CE, Grenzach Wyhlem, Germany

[15] Ctr HIV Hepatogastrenterol, Dusseldorf, Germany

来源：

JOURNAL OF HEPATOLOGY | 2009年 / 50卷

关键词：

D O I：

10.1016/S0168-8278(09)60653-X

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

651

引用

页码：S239 / S240

页数：2

共 50 条

[1] Role of Rvr and Viral Load On SVR in Treatment of GT3 Hepatitis C Patients with Peginterferon Alfa-2a (PEG) and Ribavirin (RBV) in Real Life
Zehnter, Elmar
Hueppe, Dietrich
Kaiser, Stephan
Schober, Andreas
Schuchmann, Marcus
Boeker, Klaus
Moog, Gero
Schiffelholz, Willibold
Pape, Stefan
Heyne, Renate
Ackermann, Frank
Schmidt, Wolfgang
John, Christine
Lohmeyer, Juergen
Hey, Karl-Heinz
Alshuth, Ulrich
Mauss, Stefan
GASTROENTEROLOGY, 2009, 136 (05) : A839 - A839
[2] CONFIRMATION OF HIGH SVR RATES AFTER SHORTENING DURATION OF TREATMENT WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) IN CHRONIC HEPATITIS C (CHC) PATIENTS WITH RVR IN REAL LIFE
Baloch, Baby Kanwal
Chen, Liqiong
Irving, William
Ilyas, Mohammad
Thomson, Brian J.
HEPATOLOGY, 2011, 54 : 806A - 807A
[3] Viral Response at Week 2 as a Predicitive Factor for Rvr in Chronic Hepatitis C Genotype 1 Infection Treated With Peginterferon Alfa-2A (PEG) and Ribavirin (RBV)
Mauss, Stefan
Lutz, Thomas
Boeker, Klaus H.
Link, Ralph
Moog, Gero
Stoehr, Albrecht D.
Baumgarten, Axel
Heyne, Renate
Eisenbach, Christoph
Teuber, Gerlinde
Weber, Bernd
Schott, Eckart
Hillenbrand, Heribert
Alshuth, Ulrich
Hueppe, Dietrich
Buggisch, Peter
GASTROENTEROLOGY, 2012, 142 (05) : S958 - S958
[4] The role of cholesterol on sustained virological response (SVR) in the treatment of genotype-1 infected hepatitis C (cHC) patients with peginterferon Alfa-2a (PEG) and ribavirin (RBV)
Mauss, Stefan
Zehnter, Elmar
Hueppe, Dietrich
Kaiser, Stephan
Becker, Klaus
Lutz, Thomas
Heyne, Renate
John, Christine
Moog, Gero
Schober, Andreas
Pfaff, Rainer
Zipf, Andreas
Racky, Stefan A.
Lohmeyer, Jueregn
Bokemeyer, Bernd
Kallinowski, Birgit
Witthoeft, Thomas
Alshuth, Ulrich
GASTROENTEROLOGY, 2008, 134 (04) : A829 - A829
[5] Predicitive Factors for Nonresponse in Genotype 2/3 Infected Chronic Hepatitis C (CHC) Patients Treated With Peginterferon Alfa-2A (PEG) and Ribavirin (RBV) in Real Life Setting
Petersen, Joerg
Lutz, Thomas
Link, Ralph
Moog, Gero
Baumgarten, Axel
Schott, Eckart
Schmidt, Wolfgang
Witthoeft, Thomas
Schnaitmann, Eiko
Seidel, Matthias
Rieke, Ansgar P.
Simon, Karl Georg
Herrmann, Andreas
Herold, Christoph
Klass, Dietmar M.
Alshuth, Ulrich
Buggisch, Peter
Mauss, Stefan
Hueppe, Dietrich
GASTROENTEROLOGY, 2012, 142 (05) : S938 - S938
[6] POTENTIAL RELEVANCE OF VIRAL RESPONSE AT WEEK 8 AS A PREDICITIVE FACTOR FOR SVR IN GENOTYPE 1 INFECTED CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) IN REAL LIFE SETTING
Mauss, Stefan
Boeker, Klaus
Zehnter, Elmar
Schober, Andreas
Moog, Gero
Lutz, Thomas
Schuchmann, Marcus
Heyne, Renate
Schiffelholz, Willi
John, Christine
Hey, Karl-Heinz
Baumgarten, Axel
Geyer, Peter R.
Pape, Stefan
Lohmeyer, Juergen
Schmidt, Wolfgang
Alshuth, Ulrich
Hueppe, Dietrich
HEPATOLOGY, 2010, 52 (04) : 777A - 777A
[7] PREDICTIVE FACTORS FOR NONRESPONSE IN GENOTYPE 2/3 INFECTED CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) IN REAL LIFE SETTING
Petersen, J.
Lutz, T.
Link, R.
Moog, G.
Baumgarten, A.
Schott, E.
Schmidt, W.
Witthoeft, T.
Schnaitmann, E.
Seidel, M.
Rieke, A.
Simon, K. G.
Herrmann, A.
Herold, C.
Klass, D.
Alshuth, U.
Buggisch, P.
Mauss, S.
Hueppe, D.
JOURNAL OF HEPATOLOGY, 2012, 56 : S454 - S454
[8] THE ROLE OF FERRITIN AS A RESPONSE MARKER FOR ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH PEGINTERFERON ALFA-2A (PEGIFN) AND RIBAVIRIN (RBV)
Klass, Dietmar M.
Zizer, Eugen
Link, Ralph
Heyne, Renate
Lutz, Thomas
Schmidt, Wolfgang
Goesseringer, Roger
Alshuth, Ulrich
Mauss, Stefan
Hueppe, Dietrich
HEPATOLOGY, 2011, 54 : 868A - 868A
[9] Differences between genotype 1 patients with SVR or relapse after treatment for chronic hepatitis C (cHC) with peginterferon Alfa-2a (40KD) (PEG) and ribavirin (RBV)
Zehnter, Elmar
Mauss, Stefan
Beoker, Klaus
Thomas, Lutz
Racky, Stefan
Schmidt, Wolfgang
Ullrich, Rainer
Sbrijer, Innessa
Heyne, Renate
Schober, Andreas
John, Christine
Hey, Karl-Heinz
Bokemeyer, Bernd
Kallinowski, Birgit
Moeller, Bernd
Pape, Stefan
Alshuth, Ulrich
Hueppe, Dietrich
GASTROENTEROLOGY, 2007, 132 (04) : A789 - A789
[10] VIRAL RESPONSE AT WEEK 2 AS A PREDICITIVE FACTOR FOR RVR IN CHRONIC HCV GENOTYPE 1 INFECTION TREATED WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV)
Mauss, S.
Lutz, T.
Boeker, K.
Link, R.
Moog, G.
Stoehr, A.
Baumgarten, A.
John, C.
Heyne, R.
Eisenbach, C.
Schiffelholz, W.
Teuber, G.
Weber, B.
Schott, E.
Hillenbrand, H.
Alshuth, U.
Hueppe, D.
Buggisch, P.
JOURNAL OF HEPATOLOGY, 2012, 56 : S450 - S450

← 1 2 3 4 5 →